GDP for Wholesale Distribution: The Responsible Person and Training

Good Distribution Practice for medicinal products for human use is set out in guidelines 2013/C 343/01, adopted on 5 November 2013, published in Official Journal C 343/1 on 23 November 2013 and applying from the following day. Chapter 2 is the personnel chapter, and it contains the obligations wholesale distributors most often under-resource — because GDP treats distribution competence as a licence condition rather than good practice.

The Responsible Person: delegation without transfer

Section 2.2 is the centre of the chapter. The Responsible Person must meet the conditions laid down by the Member State's legislation; a pharmacy degree is described as desirable rather than mandatory, alongside suitable competence, experience, and GDP knowledge and training.

Two requirements in 2.2 do the real work. The first is availability: the Responsible Person must fulfil the role personally and remain contactable at all times. The second is the accountability line — duties may be delegated, but responsibility may not. A distributor that has handed the quality system to a deputy has not moved the responsibility, and GDP expects the written job description to define the Responsible Person's decision-making authority while the distributor supplies the resources that authority needs.

The duty list in 2.2 is wider than quality oversight: overseeing the quality system and records, arranging training, coordinating recalls, handling complaints, approving suppliers, customers and subcontractors, running self-inspections, deciding the disposition of returned, recalled and falsified products, and approving returns to saleable stock. Several of those are decisions a Responsible Person cannot sensibly make without current product knowledge, which is why 2.4 requires them to keep their own GDP competence up to date through regular training.

Training must be completed before the work starts

Section 2.4 states that all personnel involved in wholesale distribution must be trained on GDP requirements, and that the training must be completed before they begin their tasks. That is a sequencing obligation, not a timetable — a new warehouse operative working a first shift with training booked for the following month is non-compliant, however good the eventual course.

The mandatory content includes product identification and avoiding falsified medicines. Staff handling products with stricter handling requirements need specific additional training, and the guidelines name temperature-sensitive products as an example. Initial and continuing training both have to follow written procedures and a written programme, so an informal on-the-job arrangement will not satisfy 2.4 even where the knowledge transfer is real.

Effectiveness, recorded periodically

All training must be recorded, and its effectiveness must be assessed and documented periodically. That is the same standard that appears across the GxP regime — GMP Chapter 2 asks for practical effectiveness to be assessed, and Annex 1 requires gowning qualification to be reassessed at least annually rather than simply delivered. A signed attendance sheet discharges the record obligation and not the effectiveness one.

The seasonal detail most sites miss

Section 9.4 contains a requirement that rarely appears in a training matrix: staff must be trained on assembling insulated shipping boxes for each season, and on reusing cool-packs. Packing configurations that hold temperature in February do not necessarily hold it in July, and GDP treats that as a competence question rather than a packing instruction. A distributor shipping temperature-sensitive product year-round should be able to show seasonal pack training, not one generic session.

Falsified medicines: a reporting sequence, not a judgement call

Training on avoiding falsified medicines is mandatory under 2.4, and section 6.4 sets what happens when one is suspected: immediate reporting to the competent authority and the marketing authorisation holder, then physical segregation of the product. The order matters. Staff who quarantine first and report later, or who escalate internally for a decision before notifying, are following a process GDP does not describe.

Brokers are in scope too. Section 10.3 requires brokerage personnel to be trained in the applicable EU and national legislation and on falsified medicines — a point worth checking if a distribution network includes brokered supply.

Staffing, structure and hygiene

Section 2.1 requires sufficient competent personnel for all tasks, with individual responsibilities understood and recorded. Section 2.3 requires an adequate number of competent staff at every stage of distribution, an organisation chart, and written job descriptions for key positions including deputies — the deputy requirement being the one most often absent when an inspector asks who covers the Responsible Person. Section 2.5 requires written procedures covering health, hygiene and clothing.

Where distribution meets manufacture

GDP does not sit in isolation. Under Annex 16, a Qualified Person certifying a batch must ensure that active substances were, where required, distributed under GDP — so a distribution failure upstream becomes a batch certification problem, as the Annex 16 certification duties set out. Distribution deviations also feed the same investigation discipline as manufacturing ones, where Chapter 1 requires human error to be justified rather than asserted, and the records underpinning all of it attract the same data integrity expectations.

What an inspector can ask for

On a Chapter 2 reading: a named Responsible Person meeting national conditions, contactable at all times, with a written job description defining decision-making authority; a documented deputy; an organisation chart with job descriptions for key roles; evidence that every person in distribution completed GDP training before starting tasks; a written initial and continuing training programme; specific training records for temperature-sensitive handling and seasonal pack assembly; periodic documented effectiveness assessment; and falsified-medicine training tied to the 6.4 reporting sequence. Structured CPD courses are one way to build and evidence that, particularly for Responsible Persons maintaining their own competence under 2.4.